Xian CP

Xi'an C.P. Pharmaceutical is a joint venture between Thailand's Charoen Pokphand (C.P.) Group and Shaanxi Pharmaceutical Holding Group, established in 1994. The company specializes in the research, development, manufacturing, and commercialization of modern Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. Its product portfolio spans multiple therapeutic areas, including oncology, gastroenterology, gynecology, dermatology, and pediatrics. Key commercial products include Canelim (Ping Xiao) capsules for cancer adjuvant therapy, Julong capsules for functional dyspepsia, and Yujin Yinxie tablets for psoriasis. Xi'an C.P. Pharmaceutical operates GMP-certified manufacturing facilities and distributes its products across China and international markets.